EWTX261218C00037000
EWTX Dec 18 2026 37.00 Call
optionOPRA
InactiveAug 4, 2026
10.50USD+31.250%(+2.50)5Vol5OI
Loading…
Underlying
Underlying Price
$39.57
Type
Call
Strike
37
Expiration
Dec 18, 2026
DTE
72d
Moneyness
ITM
Intrinsic
$2.57
EWTX 37 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9d | $7.80 | -6.02% | 1 | 4 |
| Nov 20, 2026 | 44d | $6.68 | -36.20% | 1 | 113 |
| Dec 18, 2026 | 72d | $10.50 | +31.25% | 5 | 5 |
| Jan 15, 2027 | 100d | — | — | 0 | 0 |
| Feb 19, 2027 | 135d | — | — | 0 | 0 |
| Mar 19, 2027 | 163d | $14.00 | +55.04% | 1 | 3 |
| May 21, 2027 | 226d | — | — | 0 | 0 |
EWTX Profile
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.